Get the Stockscreener App
28.12
7.65%
-2.33
Azenta Inc stock is traded at $28.12, with a volume of 841.53K.
It is down -7.65% in the last 24 hours and down -25.09% over the past month.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
See More
Previous Close:
$30.45
Open:
$30.2
24h Volume:
841.53K
Relative Volume:
1.13
Market Cap:
$1.30B
Revenue:
$604.93M
Net Income/Loss:
$-31.91M
P/E Ratio:
-11.62
EPS:
-2.42
Net Cash Flow:
$45.67M
1W Performance:
+0.97%
1M Performance:
-25.09%
6M Performance:
-3.73%
1Y Performance:
-37.95%
1-Day Range:
$27.71
$30.30
1-Week Range:
$27.27
$30.74
52-Week Range:
$23.91
$47.55
Azenta Inc Stock (AZTA) Company Profile
Name
Azenta Inc
Sector
Industry
Phone
(978) 262-2400
Address
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
28.12 | 1.40B | 604.93M | -31.91M | 45.67M | -2.42 |
|
ISRG
Intuitive Surgical Inc
|
478.60 | 176.19B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
177.81 | 51.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
78.55 | 39.00B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
44.59 | 37.48B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
245.73 | 37.82B | 5.40B | 1.49B | 1.78B | 10.12 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-25 | Reiterated | Needham | Buy |
| Oct-30-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-06-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-22-25 | Resumed | Stephens | Equal-Weight |
| Dec-18-24 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-04-24 | Initiated | Jefferies | Hold |
| Feb-01-24 | Reiterated | B. Riley Securities | Buy |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| May-10-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-09-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-22 | Resumed | B. Riley Securities | Buy |
| Mar-21-22 | Initiated | Evercore ISI | Outperform |
View All
Azenta Inc Stock (AZTA) Latest News
FOMO Trade: Can Azenta Inc keep up with sector leadersTreasury Yields & Capital Efficiency Focused Ideas - baoquankhu1.vn
Bio-Preservation Market to Reach US$ 44.45 Billion by 2035 | Cold Chain Expansion and Cell & Gene Therapy Commercialization Drive Growth Says Astute Analytica - GlobeNewswire Inc.
Why Azenta Inc. (BA3) stock is trending on social mediaJuly 2025 Breakouts & Technical Confirmation Alerts - mfd.ru
Azenta partners with Frontier Space to advance space research By Investing.com - Investing.com South Africa
Azenta (AZTA) Forms Strategic Alliance with Frontier Space for S - GuruFocus
Azenta Life Sciences and Frontier Space Announce Strategic Partnership - citybiz
Azenta Teams Up With Frontier Space for Space-Based Scientific Experiments - marketscreener.com
How Azenta's lab tubes are being tested for life science in space - Stock Titan
Azenta stock hits 52-week high at $28.44 despite yearly decline - Investing.com
Does Azenta (AZTA) Earnings, Buyback Pause, and Board Change Hint at a Strategic Crossroads? - Yahoo Finance
Azenta Earnings Call: Margins Squeezed, Outlook Steady - TipRanks
Decoding Azenta Inc (AZTA): A Strategic SWOT Insight - GuruFocus
Azenta (NASDAQ:AZTA) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
Tech Rally: Can Azenta Inc sustain earnings growthPortfolio Performance Report & Low Risk Entry Point Tips - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC) and Azenta (AZTA) - The Globe and Mail
Stocks making big moves yesterday: Azenta, FTAI Aviation, Reddit, Columbia Sportswear, and RenaissanceRe - Finviz
Azenta (AZTA): Evercore ISI Group Lowers Price Target but Mainta - GuruFocus
Cold Chain, High Stakes: A Deep Dive into Azenta’s (AZTA) Life Sciences Transformation - FinancialContent
Azenta, Inc. (NASDAQ:AZTA) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Azenta Q4 2025 Results: Revenue Exceeds Estimates, Profit In LineNews and Statistics - IndexBox
Azenta, Inc. (NASDAQ:AZTA) Q1 2026 Earnings Call Transcript - Insider Monkey
AZTA Q4 Deep Dive: Operational Challenges and Turnaround Efforts Dominate Results - Finviz
Azenta outlines 3% to 5% organic revenue growth and 300bps margin expansion for 2026 amid macro uncertainty - MSN
Azenta Q1 2026 slides: Revenue edges up 1% while organic growth declines, stock plunges - Investing.com Nigeria
Azenta (AZTA) Returns To Quarterly EPS Loss Challenging Recent Profitability Narrative - Sahm
Cowen Maintains Hold on Azenta, Inc. (AZTA) Feb 2026 - Meyka
Where Azenta Stands With Analysts - Benzinga
Azenta Inc (AZTA) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic Focus ... By GuruFocus - Investing.com Canada
Azenta stock price target lowered to $30 by TD Cowen on margin pressure - Investing.com UK
Azenta stock price target lowered to $30 by TD Cowen on margin pressure By Investing.com - Investing.com Nigeria
Jefferies Lowers Azenta (AZTA) Price Target, Maintains Buy Ratin - GuruFocus
Jefferies Financial Group Has Lowered Expectations for Azenta (NASDAQ:AZTA) Stock Price - MarketBeat
Needham Reiterates "Buy" Rating for Azenta (AZTA) with $44 Price Target | AZTA Stock News - GuruFocus
Azenta (NASDAQ:AZTA) Given Buy Rating at Needham & Company LLC - MarketBeat
Azenta (AZTA) Stock Trades Down, Here Is Why - Finviz
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Azenta shares slide after Q1 earnings come in below forecasts - MSN
Azenta Stock Falls 22% Over Wider Loss EPS In Q1 - Nasdaq
Azenta (NASDAQ:AZTA) Shares Gap Down on Disappointing Earnings - MarketBeat
Azenta Q1 2026 slides: Revenue edges up 1% while organic growth declines, stock plunges By Investing.com - Investing.com South Africa
Azenta Q1 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: Azenta Q1 2026 misses EPS, stock falls By Investing.com - Investing.com India
Earnings call transcript: Azenta Q1 2026 misses EPS, stock falls - Investing.com
Azenta (NASDAQ:AZTA) Issues Quarterly Earnings Results - MarketBeat
Azenta's (NASDAQ:AZTA) Q4 CY2025: Beats On Revenue - Finviz
Azenta’s (NASDAQ:AZTA) Q4 CY2025: Beats On Revenue - Yahoo Finance
Azenta: Q1 Earnings Insights - Benzinga
Azenta shares fall 6% as first quarter earnings miss estimates By Investing.com - Investing.com Australia
Earnings Flash (AZTA) Azenta, Inc. Reports Q1 Revenue $149.0M, vs. FactSet Est of $147.1M - marketscreener.com
Earnings Flash (AZTA) Azenta, Inc. Posts Q1 Adjusted EPS $0.09 per Share, vs. FactSet Est of $0.14 - marketscreener.com
Azenta shares fall 6% as first quarter earnings miss estimates - Investing.com
Azenta Inc Stock (AZTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):